Archive of Presentations
from a Workshop on
Innovation in the Life Sciences:
Intellectual Property and Public Investment
for Pharmaceuticals and Agriculture
Convened by the
Program on Science, Technology, and Global Development
The Earth Institute at Columbia University
May 20-21, 2004
Thursday, May 20th: Background and Proposals for Reform
8:45 to 9:15 Welcome and Introductions
Jeffrey Sachs (Columbia)
PART I: THE CURRENT CONTEXT
Chair: Will Masters
9:15 to 10:15 Agriculture
Bob Evenson (Yale): From the Green Revolution to the Gene Revolution
Related paper: "Total Factor Productivity Growth In Agriculture: the Role of Technological Capital" (PDF)
Brian Wright (Berkeley): Intellectual Property Rights in Agriculture
Phil Pardey (Minnesota): Funding and Effectiveness of Agricultural Research
Related papers: Creating, Protecting, and using Crop Technologies Worldwide in an Era of Intellectual Property
10:15 to 10:30 Break
10:30 to 11:45 Pharmaceuticals I
Rebecca Henderson (MIT): Drug Discovery and Development
John Barton (Stanford): Intellectual Property Rights in Pharmaceuticals
Annetine Gelijns and Alan Moskowitz (Columbia): Pharmaceutical Innovation: the Role of Academia
11:45 to 1:00 Pharmaceuticals II
Pierre Azoulay (Columbia): The Economics of Clinical Research
Mark Hovde (Hovde Associates): The Cost of Clinical Trials
Warren Kaplan (Boston University): Priority Setting in the Private Sector
1:00 to 2:00 Lunch
Jeffrey Sachs (Columbia): R&D in the Life Sciences: Alternatives to Patents
PART II: PROPOSALS FOR REFORM
Chair: Richard Nelson
2:00 to 3:00 Voluntary Initiatives: prizes and pull mechanisms
Michael Kremer (Harvard): Vaccine Purchase Commitments and Other Pull Mechanisms
Will Masters (Columbia): Prizes for Successful Innovation in African Agriculture
Anil K. Gupta (IIM Ahmedabad, India): Rewarding Grassroots Innovators
3:00 to 4:15 Voluntary Initiatives: IPR exchanges and clearinghouses
David Zilberman (Berkeley): Clearinghouses for IPR: Improving Access and Efficiency
Deborah Delmer (Rockefeller Foundation): Update on PIPRA
Eugene Terry (African Agricultural Technology Foundation): Update on AATF
Anthony So (Duke): Enabling Conditions for the Scientific Commons
4:15 to 4:30 Break
4:30 to 5:30 Proposals for Reform: Legislative Approaches
Jean Lanjouw (Berkeley): Instituting a Foreign Filing License (FFL) for Drug Patents. A 4 page summary and a related 40-page article are also available.
Tim Hubbard (Wellcome Trust): An International Treaty on R&D Investment
Jamie Love (CP Tech): Competitive Intermediaries and Prize Mechanisms
5:30 to 6:00 Open Discussion of Proposals
6:00 Reception and Dinner at the Kellogg Center
Friday, May 21st: Discussion of Reform Proposals
PART III: PANEL DISCUSSION OF REFORM PROPOSALS
Chair: Francoise Torchiana (Ethical Globalization Initiative)
8:30 to 9:15 Panel I: Overview
Richard Nelson (Columbia)
Claude Henry (Polytechnique, Paris): Comments on Compulsory Licenses and Opposition Procedures
Vern Ruttan (Minnesota): Island Empires: Linking Knowledge to Action
9:15 to 10:30 Panel II: Pharmaceuticals - Perspectives from the Law
Harold Edgar (Columbia Law School)
Terry Fisher (Harvard Law School)
Hugh C. Hansen (Fordham Law School)
Jerome Reichman (Duke Law School)
Yochai Benkler (Yale Law School): Commons-Based Strategies for Development
10:30 to 10:45 Break
PART IIIb: PANEL DISCUSSION OF REFORM PROPOSALS (continued)
Chair: Pedro Conceição (UNDP)
10:45 to 11:45 Panel III: Pharmaceuticals - Perspectives from Economics
Henry Grabowski (Duke): Alternatives to the Patent System
Bhaven Sampat (Georgia Tech/Michigan)
Shyama Ramani (INRA and Polytechnique, Paris): Tripping over TRIPS? Implications for the Biotech Segment of the Indian Pharmaceuticals Industry
Luigi Orsenigo (University of Brescia, Italy)
11:45 to 1:00 Panel IV: Pharmaceuticals - Perspectives from the Trenches
Merrill Goozner (CSPI): The $800 million Pill: The Truth Behind the Cost of New Drugs
Jeffrey Kemprecos (Merck): Improving Human Health: The View of a Research Pharmaceutical Company
Fabio Pammolli (U. of Florence, WHO Commission on IPRs and Public Health)
Dan Ravicher (Public Patent Foundation)
1:00 to 2:00 Lunch
PART IIIc: PANEL DISCUSSION OF REFORM PROPOSALS (continued)
Chair: Sakiko Fukuda-Parr, UNDP
2:00 to 3:30 Panel V: Agriculture
Dana Dalrymple (USAID): Context and Reform in Agriculture
Simeon Ehui (The World Bank)
Carl Pray (Rutgers): Patents, Prizes, the Private Companies, and African Farmers
Michel Trommetter (INRA and Polytechnique, Paris): Agriculture and Biotechnology: How to Create a CHM in France?
3:30 to 3:45 Break
3:45 to 5:00 Wrap-up: Where do we go from here?
Richard Nelson and Will Masters (Columbia)
Return to the "Innovation in the Life Sciences" workshop homepage